Qyuns Therapeutics Co (HKSE:02509) YoY EBITDA Growth : 100.00% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Qyuns Therapeutics Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 100.00%.

Qyuns Therapeutics Co's EBITDA per Share for the three months ended in Jun. 2024 was HK$0.00.

Qyuns Therapeutics Co YoY EBITDA Growth Historical Data

The historical data trend for Qyuns Therapeutics Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co YoY EBITDA Growth Chart

Qyuns Therapeutics Co Annual Data

Trend

Dec21

Dec22

Dec23

YoY EBITDA Growth

37.36

-75.81

Qyuns Therapeutics Co Quarterly Data
	Dec21	Sep22	Dec22	Jun23	Sep23	Dec23	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial			-	-	-	-	100.00

Qyuns Therapeutics Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Qyuns Therapeutics Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-2.326	-	-1.323)	/	\| -1.323 \|
=	-75.81 %

Qyuns Therapeutics Co's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(0	-	-0.471)	/	\| -0.471 \|
=	100.00 %

Qyuns Therapeutics Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Qyuns Therapeutics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN

Website

http://www.qyuns.net

Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.

Executives

Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si	2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si	2201 Interest of corporation controlled by you
Qing Dao Xin Chen Ke Chuang Shi Ye You Xian Gong Si
Zi Jin Xin Tuo You Xian Ze Ren Gong Si
Tai Zhou Hua Cheng Yi Xue Tou Zi Ji Tuan You Xian Gong Si
Nan Jing Zi Jin Tou Zi Ji Tuan You Xian Ze Ren Gong Si
Nan Jing Shi Guo You Zi Chan Tou Zi Guan Li Kong Gu Ji Tuan You Xian Ze Ren Gong Si
Bei Jing Hong Tai Tong Chuang Tou Zi Guan Li You Xian Gong Si
Sheng Xi Tai
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si	2201 Interest of corporation controlled by you
Hu Kaijun	2201 Interest of corporation controlled by you
Yu Guo'an
Hangzhou Quanyi Investment Management Partnership (general Partnership)

Qyuns Therapeutics Co Headlines

No Headlines